Article
Management strategies using pharmacogenomics in patients with severe HCV-1b infection: a decision analysis.
Hepatology (Baltimore, Md.) - 1 Jul 2002
Moriguchi Hisashi, Uemura Takamoto, Kobayashi Makoto, Chung Raymond T, Sato Chifumi
Abstract excerpt
The management of interferon (IFN) therapy for histologically severe chronic hepatitis C virus genotype 1b (HCV-1b [F3]) is controversial. A decision analysis using the Markov decision analysis model was performed for 6 disease management strategies by using clinical data from a Japanese teaching hospital and available published data. The results of base case analyses showed that IFN monotherapy was considered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
